Ramantamig
- Listing at source
- Listed
- Drug name
- Ramantamig
- jnj 79635322
- JNJ-79635322
- ramantamig
- Ramantamig
- FDA ingredient codes (UNII)
- L97FGF546Q
Related records
Trials (4)
- A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
- A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
- A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
- A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible